HEART MORPHOLOGICAL CHANGES IN METABOLIC SYNDROME AND THEIR ROLE IN CARDIOVASCULAR RISK AND TREATMENT STRATEGIES

Abstract

Metabolic syndrome (MetS) is a group of interconnected risk factors that significantly increase the likelihood of cardiovascular diseases, type 2 diabetes, and other metabolic disorders. Among the various components of MetS, morphological changes in the heart are becoming increasingly recognized for their role in cardiovascular dysfunction. This article explores the key morphological alterations in the heart associated with MetS, including left ventricular hypertrophy, myocardial fibrosis, and changes in heart chamber dimensions. The underlying mechanisms, such as insulin resistance, chronic inflammation, and oxidative stress, contribute to these structural changes, leading to impaired cardiac function and an elevated risk of heart failure, arrhythmias, and coronary artery disease. The article further discusses the implications of these changes for cardiovascular health, emphasizing the importance of early detection and intervention. Finally, it outlines potential treatment strategies aimed at preventing or reversing these cardiac alterations to improve long-term cardiovascular outcomes in individuals with MetS.